Ron Lacks Criticized Johns Hopkins Over Memorial
The estate executor alleged he was excluded from planning the upcoming Henrietta Lacks Memorial Lecture.
Updated on Oct. 10, 2026 in Cancer
Live Poll
Should the families of deceased persons have veto power over events held in their name?
Ron Lacks, the executor of the estate of Henrietta Lacks, has publicly criticized Johns Hopkins for his exclusion from the 16th annual Henrietta Lacks Memorial Lecture. Lacks expressed his grievances on social media after being denied a request to host a table for his book at the event.
Why it matters
The dispute highlights ongoing tensions regarding the legacy and recognition of Henrietta Lacks, whose cells were taken at Johns Hopkins Hospital in 1951. While the estate has pursued legal settlements with various firms, disagreements persist over how the institution honors her name and manages relationships with her descendants.
Henrietta Lacks passed away at age 31 in 1951, leaving behind five children. Her legacy now spans 75 years of medical history, during which the estate has pursued various legal actions against biotechnology and pharmaceutical companies.
The players
Ron Lacks
He serves as the executor of the estate of Henrietta Lacks and has been an active voice in discussions regarding her medical legacy.
Johns Hopkins
This Baltimore-based institution is home to the hospital where the original cell samples were collected and currently hosts annual memorial lectures.
Henrietta Lacks
She was a woman whose cancer cells were collected without her knowledge in 1951, eventually becoming a cornerstone of modern biomedical research.
The details
Ron Lacks claimed that he was excluded from the planning process for the event, which is set to take place at the institution that maintains it never profited from his grandmother's cells. This conflict follows a series of recent settlements the estate reached with companies like Novartis and Viatris in 2026.
Timeline
Henrietta Lacks provided cell samples and died in 1951.
The estate reached its first major settlement with Thermo Fisher in 2023.
Johns Hopkins broke ground on a research building in 2024.
The estate reached a settlement agreement with Novartis in February 2026.
Johns Hopkins is scheduled to host the 16th annual memorial lecture on October 10, 2026.
The Big Picture
This dispute follows the 2023 settlement between the Henrietta Lacks estate and Thermo Fisher Scientific, which marked a shift in how the estate engages with corporations using the original cell line. The current friction illustrates that legal settlements regarding cell usage have not fully resolved the complex interpersonal and commemorative tensions between the family and the hospital.
Residents in Baltimore may notice increased attention toward the hospital's research building, which now bears the name of Henrietta Lacks. The ongoing dispute serves as a reminder to the public about the evolving nature of medical ethics, patient rights, and institutional accountability regarding historical cell samples.
The takeaway
The tension between institutional commemorations and family input highlights the ongoing complexity of medical legacies. Families navigating similar histories often face challenges in balancing public recognition with private rights and expectations of inclusion.
Further reading
For more information on the history of this topic, visit the Cancer section.
Source note: This article includes information reported by TheGrio.
Live Poll
Should the families of deceased persons have veto power over events held in their name?
